FiX study
Examination of prevalence, severity, and state of screening and treatment
Investigators
PI: Dr. Martina Schmidt
Co-PI: Prof. Dr. Karen Steindorf
Abstract
After a cancer treatment, beyond therapy success the quality of life is of great importance. Therefore, we want to advance research and development of patient-oriented offers and treatments in order to alleviate common side effects such as fatigue (extreme exhaustion) and to improve quality of life of cancer survivors.
The FiX study is an important step in this regard. In Germany, guidelines for the treatment of cancer-related fatigue as well as systematically collected comparative data on the prevalence and severity of fatigue in the various types of cancer are still missing.
The aim of the study is therefore to identify existing problems as well as patient groups with a particularly high need for action regarding fatigue.